Amelioration of rheumatoid arthritis (RA) occurs in about three quarte
rs of pregnancies. Most women who improve experience initial relief in
the first trimester. RA almost invariably recurs within 3 to 4 months
of delivery. The effect of pregnancy upon the risk of first developin
g RA is similar in some respects but also differs from that observed i
n women with established disease. Analogous to women with established
disease, the chance of a woman first developing RA is significantly re
duced during pregnancy but increased in the first year post partum; th
ereafter risk is decreased. There is no indication of any adverse effe
cts of RA on pregnancy outcome. Although limited, some medications can
be used during pregnancy and during lactation without jeopardizing th
e well-being of the fetus.